Sunday, 30 August 2026 SourcesAbout🌓
🇿🇦 ZA ▾
BREAKING
Latest

AstraZeneca’s asthma drug succeeds in late-stage oesophagitis trial

TimesLIVE ·
AstraZeneca’s asthma drug succeeds in late-stage oesophagitis trial

AstraZeneca said on Thursday its asthma drug, Tezspire, developed with Amgen, met its main and secondary goals in a late-stage trial for treating eosinophilic oesophagitis, a chronic inflammatory disorder of the oesophagus

Read the full article on TimesLIVE ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.timeslive.co.za — the content belongs to TimesLIVE.

More from TimesLIVE

See all ›

More in Latest

See all ›